How to appeal a Spravato denial
The short answer
Plans usually deny Spravato when the request does not show that at least two antidepressants failed, each taken long enough at a full dose. Get your plan's written criteria and ask your psychiatrist to list every antidepressant with doses, dates and results. Spravato is given in a certified clinic, so check whether your plan handles it under the medical or the pharmacy benefit.
- StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
- Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
- Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.
Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.
What Spravato is approved for
Spravato (esketamine) is a nasal spray. As of November 2026 its FDA label lists two uses in adults:
- Treatment-resistant depression, alone or with an oral antidepressant.
- Depressive symptoms in major depressive disorder with acute suicidal thoughts or behavior, with an oral antidepressant.
It is only available through a restricted program, the SPRAVATO REMS. You take it at a certified health care setting, and staff observe you for at least 2 hours after each dose.
Why plans deny Spravato
One insurer's national policy recommends prior authorization for Spravato. For treatment-resistant depression, it asks for:
- Age 18 or older.
- No response, meaning 25 percent improvement or less, to at least two antidepressants from different classes, such as an SSRI and an SNRI.
- Each one taken at a therapeutic dose for at least 6 weeks in the current episode.
- A check of the state prescription drug monitoring program.
- A psychiatrist or mental health provider prescribing or consulting.
For depression with suicidal thoughts, it asks that the patient is taking at least one oral antidepressant at the same time. Denials often come from two drugs in the same class, trials shorter than 6 weeks, or missing doses.
Reading the denial
Job-based plans must name the specific plan provision behind a denial, and you can ask for a free copy of the criteria. "Criteria not met" means the plan wanted more medical proof; see prior authorization denials. "Step therapy" or "try a preferred product first" means the plan wants another drug tried; see step therapy denials. "Non-formulary" means Spravato is not on the drug list, which calls for a formulary exception. Check your plan's drug list to see what it prefers.
What your doctor's letter should document
Ask for a letter of medical necessity that answers each criterion, in order, with dated records:
- The diagnosis and its diagnosis code.
- Every antidepressant in the current episode: name, class, dose, start and stop dates, and the result.
- Depression scores before and after each trial, if you have them.
- Any history of psychosis, and the prescriber's view on it.
- For renewals, specific signs of benefit since starting Spravato.
Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.
If Spravato is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.
If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.
Medicare, Medicaid and manufacturer help
With a Medicare drug plan, ask for a coverage determination or exception. Your prescriber must provide a statement explaining the medical reason. The plan must decide within 72 hours, or 24 hours if expedited, and Part D exceptions can also cover step therapy and dose limits. You have 65 days to appeal a denial. See Part D appeals.
When a clinic gives the drug, Medicare may pay under Part B instead. Medicare.gov says Part B usually covers drugs you wouldn’t typically give to yourself, like those given in a doctor's office, and most injectable and infused drugs when a licensed provider gives them. Ask the clinic which part of Medicare it is billing, because the appeal path differs. See Original Medicare appeals.
State Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.
Johnson & Johnson runs the SPRAVATO withMe Savings Program for eligible patients with commercial or private insurance.
Questions people ask
How many antidepressants do I need to try before Spravato?
Usually at least two. One policy asks for no response to two antidepressants from different classes, each taken for at least 6 weeks at a therapeutic dose.
Does Medicare cover Spravato?
Medicare can. Because staff give it in a clinic, ask whether the clinic bills Part B or your Part D plan. Medicare.gov says Part B usually covers drugs given in a doctor's office that you would not give yourself.
Insurance stopped covering Spravato after I'd been on it. What can I do?
First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.
What if my Spravato appeal is denied?
If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.
Sources
- National Library of Medicine (DailyMed): SPRAVATO (esketamine) nasal spray prescribing information (DailyMed)
Treatment-resistant depression (TRD) in adults as monotherapy or in conjunction with an oral antidepressant
- Cigna Healthcare: Psychiatry – Spravato Prior Authorization Policy (Cigna National Formulary, review date 04/29/2026)
Prior Authorization is recommended for prescription benefit coverage of Spravato.
- eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedure
Reference to the specific plan provisions on which the determination is based
- HealthCare.gov: Getting prescription medications
Visit your insurer’s website to review a list of prescriptions your plan covers
- HealthCare.gov: Internal appeals
You must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
- eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefits
A health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
- HealthCare.gov: External Review
You must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
- Medicare.gov: Appeals in a Medicare drug plan
If you're asking for an exception, your prescriber must provide a statement explaining the medical reason why the exception should be approved.
- eCFR (Office of the Federal Register): 42 CFR 423.568 -- Standard timeframe and notice requirements for coverage determinations
but no later than 72 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.572 -- Timeframes and notice requirements for expedited coverage determinations
but no later than 24 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.578 -- Exceptions process
An exception to a plan's coverage policy that causes a Part D prescription drug not to be covered because of cost utilization tools, such as a requirement for step therapy, dosage limitations, or therapeutic substitution.
- Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs
A State may subject to prior authorization any covered outpatient drug
- Medicare.gov: Prescription drugs (outpatient)
Usually, Part B covers drugs you wouldn't typically give to yourself, like those you get at a doctor's office or in a hospital outpatient setting.
- Johnson & Johnson: SPRAVATO withMe Savings Program requirements
You may be eligible for the SPRAVATO withMe Savings Program if you are:
- eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugs
Ensure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.
This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.